This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Are you in your 20s and wondering if a financial advisor is right for you? Learn who should consider seeking professional financial help.
26,867 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Investors are urged to rethink risk in today’s markets: volatility is temporary, but liquidity squeezes and balance-s...
Navigate Neptune's Q4 2025 performance, understand margin dynamics, and gauge 2026 guidance. This practical guide exp...
As TTEC heads into 2025 earnings season, investors want a clear view of what could drive the numbers. This guide brea...
A major fund trimmed its LKQ position by 777,000 shares, raising questions about what this means for the stock and th...
A House committee hearing on digital asset taxation highlighted sharp divides among lawmakers on urgency and approach...
SpaceX plans to push Starship through another high-stakes test flight. Here’s what investors should watch, how it cou...
A hantavirus outbreak unfolds, missing a coordinated federal response, leaving travelers and insurers scrambling for ...
GameStop is targeting a larger authorized share count to keep financing options flexible. This move sparks questions ...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
A big stock move and a buyout rumor are reshaping how traders view NCR Atleos. A large block sale drew attention, jus...
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...